Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00140036|
Recruitment Status : Completed
First Posted : August 31, 2005
Last Update Posted : March 3, 2008
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Neoplasms||Procedure: Blood draw||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||137 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).|
|Study Start Date :||September 2002|
|Study Completion Date :||August 2005|
- Correlation of genotype with safety and efficacy measures.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00140036
Show 34 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|